Physician profile
Daniel E Torres
NPI 1972810067
$1,304.82
in general payments reported to CMS, 2019-2025
7 companies · $41.69 in 2025
The $41.69 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $120 · 2021: $105 · 2022: $173 · 2023: $654 · 2024: $46.21 · 2025: $41.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $401 · Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $400.99 |
| Food and Beverage | $341.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $838.35 | 2020-2024 | |
| Kls-Martin L.P. | $112.11 | 2022 | |
| Dentsply Sirona INC | $97.94 | 2019-2021 | |
| Salvin Dental Specialties, INC. | $93.91 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $78.85 | 2019-2025 | Exparel |
| Nobel Biocare USA | $68.97 | 2019-2020 | |
| Kulzer, LLC | $14.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.